These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 19167122)

  • 1. A randomized phase II study of cisplatin/5-FU concurrent chemoradiotherapy for esophageal cancer: Short-term infusion versus protracted infusion chemotherapy (KROSG0101/JROSG021).
    Nishimura Y; Mitsumori M; Hiraoka M; Koike R; Nakamatsu K; Kawamura M; Negoro Y; Fujiwara K; Sakurai H; Mitsuhashi N
    Radiother Oncol; 2009 Aug; 92(2):260-5. PubMed ID: 19167122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up of a randomized Phase II study of cisplatin/5-FU concurrent chemoradiotherapy for esophageal cancer (KROSG0101/JROSG021).
    Nishimura Y; Hiraoka M; Koike R; Nakamatsu K; Itasaka S; Kawamura M; Negoro Y; Araki N; Ishikawa H; Fujii T; Mitsuhashi N
    Jpn J Clin Oncol; 2012 Sep; 42(9):807-12. PubMed ID: 22811410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, multicenter, phase IIb study of preoperative chemoradiotherapy in T3 mid-distal rectal cancer: raltitrexed + oxaliplatin + radiotherapy versus cisplatin + 5-fluorouracil + radiotherapy.
    Valentini V; Coco C; Minsky BD; Gambacorta MA; Cosimelli M; Bellavita R; Morganti AG; La Torre G; Trodella L; Genovesi D; Portaluri M; Maurizi-Enrici R; Barbera F; Maranzano E; Lupattelli M
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):403-12. PubMed ID: 17919844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: Results at 2 years (FNCLCC-GORTEC).
    Bensadoun RJ; Bénézery K; Dassonville O; Magné N; Poissonnet G; Ramaïoli A; Lemanski C; Bourdin S; Tortochaux J; Peyrade F; Marcy PY; Chamorey E; Vallicioni J; Seng H; Alzieu C; Géry B; Chauvel P; Schneider M; Santini J; Demard F; Calais G
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):983-94. PubMed ID: 16376489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group study.
    Lanciano R; Calkins A; Bundy BN; Parham G; Lucci JA; Moore DH; Monk BJ; O'Connor DM
    J Clin Oncol; 2005 Nov; 23(33):8289-95. PubMed ID: 16230678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late course accelerated hyperfractionated radiotherapy plus concurrent chemotherapy for squamous cell carcinoma of the esophagus: a phase III randomized study.
    Zhao KL; Shi XH; Jiang GL; Yao WQ; Guo XM; Wu GD; Zhu LX
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1014-20. PubMed ID: 15990003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102.
    Bedenne L; Michel P; Bouché O; Milan C; Mariette C; Conroy T; Pezet D; Roullet B; Seitz JF; Herr JP; Paillot B; Arveux P; Bonnetain F; Binquet C
    J Clin Oncol; 2007 Apr; 25(10):1160-8. PubMed ID: 17401004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous infusion of 5-fluorouracil with versus without low-dose, consecutive administration of cisplatin in advanced colorectal cancer. A prospective randomized phase II study.
    Nakata B; Sowa M; Tsuji A; Kamano T; Sasaki K; Fukunaga Y; Takahashi M; Tsujitani S; Mikami Y; Mitachi Y; Nishimura S; Araki H; Yamamitsu S; Hirakawa K; Tominaga S; Shirasaka T; Inokuchi K
    J Exp Clin Cancer Res; 2007 Mar; 26(1):51-60. PubMed ID: 17550132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of treatment tolerance and outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy in a prospective randomized trial or with standard treatment.
    Torres MA; Jhingran A; Thames HD; Levenback CF; Bodurka DC; Ramondetta LM; Eifel PJ
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):118-25. PubMed ID: 17869451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of china.
    Chen Y; Liu MZ; Liang SB; Zong JF; Mao YP; Tang LL; Guo Y; Lin AH; Zeng XF; Ma J
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1356-64. PubMed ID: 18472356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Concurrent chemoradiotherapy using protracted infusion of low-dose CDDP and 5-FU and radiotherapy for esophageal cancer].
    Itoh Y; Fuwa N; Matsumoto A; Asano A; Sasaoka M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1999 Jul; 59(8):395-401. PubMed ID: 10459284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized phase II study of cisplatin and 5-FU continuous infusion (PF) versus cisplatin, UFT and vinorelbine (UFTVP) as induction chemotherapy in locally advanced squamous cell head and neck cancer (LA-SCHNC).
    Rivera F; Vega-Villegas ME; López-Brea M; Isla D; Mayorga M; Galdós P; Rubio A; Del Valle A; García-Reija F; García-Montesinos B; Rodríguez-Iglesias J; Mayordomo J; Rama J; Saiz-Bustillo R; Sanz-Ortiz J
    Cancer Chemother Pharmacol; 2008 Jul; 62(2):253-61. PubMed ID: 17901953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Locoregionally advanced nasopharyngeal carcinoma: induction chemotherapy with cisplatin and 5-fluorouracil followed by radiotherapy and concurrent cisplatin: a phase II study.
    Ferrari D; Chiesa F; Codecà C; Calabrese L; Jereczek-Fossa BA; Alterio D; Fiore J; Luciani A; Floriani I; Orecchia R; Foa P
    Oncology; 2008; 74(3-4):158-66. PubMed ID: 18714164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent chemoradiotherapy with cisplatin and fluorouracil for locally advanced hypopharyngeal carcinoma.
    Yoon MS; Chung WK; Ahn SJ; Nam TK; Nah BS; Song JY; Lim SC; Lee JK
    Acta Otolaryngol; 2008 May; 128(5):590-6. PubMed ID: 18421617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicity and feasibility analysis for cisplatin-based concomitant chemoradiotherapy in locally advanced nasopharyngeal carcinoma.
    Atasoy BM; Dane F; Yumuk PF; Akgün Z; Turhal NS; Abacioğlu U; Sengöz M
    J BUON; 2008; 13(1):43-50. PubMed ID: 18404785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overall survival with cisplatin and 5-fluorouracil neoadjuvant treatment in patients with esophageal cancer: single-center experience.
    Idelevich E; Buyevich V; Machlenkin S; Ziv-Sokolovsky N; Dinerman M; Brenner B; Kashtan H
    Onkologie; 2008 Dec; 31(12):673-7. PubMed ID: 19060505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiochemotherapy with cisplatin and 5-fluorouracil after transurethral surgery in patients with bladder cancer.
    Weiss C; Engehausen DG; Krause FS; Papadopoulos T; Dunst J; Sauer R; Rödel C
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1072-80. PubMed ID: 17467193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of blood transfusions in patients with esophageal cancer treated with combined chemoradiotherapy.
    Kader AS; Lim JT; Berthelet E; Petersen R; Ludgate D; Truong PT
    Am J Clin Oncol; 2007 Oct; 30(5):492-7. PubMed ID: 17921709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of combination chemoradiotherapy with daily low-dose CDDP for esophageal cancer--results of a randomized trial].
    Kaneta T; Takai Y; Nemoto K; Kakuto Y; Ogawa Y; Ariga H; Maruoka S; Ishibashi T; Hosoi Y; Yamada S
    Gan To Kagaku Ryoho; 1997 Nov; 24(14):2099-104. PubMed ID: 9388519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase I trial of 5-fluorouracil with cisplatin and concurrent standard-dose radiotherapy in Japanese patients with stage II/III esophageal cancer.
    Nakajima TE; Ura T; Ito Y; Kato K; Minashi K; Nihei K; Hironaka S; Boku N; Kagami Y; Muro K
    Jpn J Clin Oncol; 2009 Jan; 39(1):37-42. PubMed ID: 19103671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.